A 24-WEEK DOUBLE-BLIND, SAFETY, EFFICACY, AND PHARMACODYNAMIC STUDY INVESTIGATING TWO DOSES OF TEDUGLUTIDE IN PEDIATRIC SUBJECTS THROUGH 17 YEARS OF AGE WITH SHORT BOWEL SYNDROME WHO ARE DEPENDENT ON PARENTERAL SUPPORT

Registry ID

TED-C14-006

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

SHIRE-NPS PHARMACEUTICALS INC.

Start date

2016-09-30

Last update

2016-05-19

Conditions

• SHORT BOWEL SYNDROME

Related clinical trials

• A 104-WEEK, MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE LONG-TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) ROLLING OVER FROM THE EASE SBS 2 OR 3 TRIALS

View on source registry